Cassandra Brooks | Feb 17, 2010 | 3 min read
Researchers have developed a novel technique for identifying patient-specific biomarkers in tumor DNA which they say can reliably monitor the progression of individual patients' cancers. Their findings are presented this week at the American Association for the Advancement of Science meeting in San Diego and will be published next week in Science Translational Medicine. Image: Courtesy of Life Technologies and Digizyme, Inc."This study pushes the limits of what we can do and what we might be